Related references
Note: Only part of the references are listed.Reactive oxygen species-responsive polymer drug delivery systems
Jiaxue Liu et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2023)
Organoboronic acids/esters as effective drug and prodrug candidates in cancer treatments: challenge and hope
Mothana K. Al-Omari et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2023)
Photoactivation of Boronic Acid Prodrugs via a Phenyl Radical Mechanism: Iridium(III) Anticancer Complex as an Example
Moyi Liu et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2023)
Boronates as hydrogen peroxide-reactive warheads in the design of detection probes, prodrugs, and nanomedicines used in tumors and other diseases
Jyun-Wei Chen et al.
DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2023)
Recent Advances in Hydrogen Peroxide Responsive Organoborons for Biological and Biomedical Applications
Eron Saxon et al.
CHEMBIOCHEM (2022)
Boronic Acid Esters and Anhydrates as Dynamic Cross-Links in Vitrimers
Mateusz Gosecki et al.
POLYMERS (2022)
Applications of the ROS-Responsive Thioketal Linker for the Production of Smart Nanomedicines
Arianna Rinaldi et al.
POLYMERS (2022)
4-Ferrocenylaniline-based ROS-responsive prodrugs with anticancer activity
Hong-Gui Xu et al.
JOURNAL OF ORGANOMETALLIC CHEMISTRY (2022)
The Boron Advantage: The Evolution and Diversification of Boron's Applications in Medicinal Chemistry
Katia Messner et al.
PHARMACEUTICALS (2022)
Allyl phenyl selenides as H2O2 acceptors to develop ROS-responsive theranostic prodrugs
Xue-Yan Yang et al.
BIOORGANIC CHEMISTRY (2022)
Thioether-based ROS responsive polymers for biomedical applications
Miryam Criado-Gonzalez et al.
JOURNAL OF MATERIALS CHEMISTRY B (2022)
Diazaborines Are a Versatile Platform to Develop ROS-Responsive Antibody Drug Conjugates**
Joao P. M. Antonio et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2021)
ROS activated prodrug for ALDH overexpressed cancer stem cells
Miae Won et al.
CHEMICAL COMMUNICATIONS (2021)
Reactive Oxygen Species (ROS)-Responsive Prodrugs, Probes, and Theranostic Prodrugs: Applications in the ROS-Related Diseases
Pengfei Wang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
An Endoplasmic Reticulum Specific Pro-amplifier of Reactive Oxygen Species in Cancer Cells
Hong-Gui Xu et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2021)
Evolution of Nitrogen-Based Alkylating Anticancer Agents
Fredrik Lehmann et al.
PROCESSES (2021)
Reactive Oxygen Species Responsive Polymers for Drug Delivery Systems
Fengxiang Gao et al.
FRONTIERS IN CHEMISTRY (2021)
5-Fluorouracil: A Narrative Review on the Role of Regulatory Mechanisms in Driving Resistance to This Chemotherapeutic Agent
Soudeh Ghafouri-Fard et al.
FRONTIERS IN ONCOLOGY (2021)
ROS-responsive dimeric prodrug-based nanomedicine targeted therapy for gastric cancer
Jiachi Ma et al.
DRUG DELIVERY (2021)
A hydrogen peroxide -activated Cu(II) pro-ionophore strategy for modifying naphthazarin as a promising anticancer agent with high selectivity for generating ROS in HepG2 cells over in L02 cells
Xia-Zhen Bao et al.
FREE RADICAL BIOLOGY AND MEDICINE (2020)
Reactive Oxygen Species (ROS)-Sensitive Prodrugs of the Tyrosine Kinase Inhibitor Crizotinib
Bjoern Bielec et al.
MOLECULES (2020)
Histone Deacetylase 2 (HDAC2) Inhibitors Containing Boron
Poya Kavianpour et al.
CHEMBIOCHEM (2020)
Arylboronic Acids and their Myriad of Applications Beyond Organic Synthesis
Noemi de Jesus Hiller et al.
EUROPEAN JOURNAL OF ORGANIC CHEMISTRY (2020)
Anticancer boron-containing prodrugs responsive to oxidative stress from the tumor microenvironment
Hichem Maslah et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
A hydrogen peroxide responsive prodrug of Keap1-Nrf2 inhibitor for improving oral absorption and selective activation in inflammatory conditions
Mengchen Lu et al.
REDOX BIOLOGY (2020)
N-Alkylaminoferrocene-Based Prodrugs Targeting Mitochondria of Cancer Cells
Viktor Reshetnikov et al.
MOLECULES (2020)
Boronic Acids and Their Derivatives in Medicinal Chemistry: Synthesis and Biological Applications
Mariana Pereira Silva et al.
MOLECULES (2020)
Role of Glutathione in Cancer: From Mechanisms to Therapies
Luke Kennedy et al.
BIOMOLECULES (2020)
Mechanistic Investigation on Oxidative Degradation of ROS-Responsive Thioacetal/Thioketal Moieties and Their Implications
Bin Liu et al.
CELL REPORTS PHYSICAL SCIENCE (2020)
Amplification of oxidative stress via intracellular ROS production and antioxidant consumption by two natural drug-encapsulated nanoagents for efficient anticancer therapy
Yihuan Liu et al.
NANOSCALE ADVANCES (2020)
Thiazolidinones: Synthesis, Reactivity, and Their Biological Applications
Sonam Nirwan et al.
JOURNAL OF HETEROCYCLIC CHEMISTRY (2019)
ROS-responsive thioether-based nanocarriers for efficient pro-oxidant cancer therapy
Yoon-Seok Kim et al.
JOURNAL OF INDUSTRIAL AND ENGINEERING CHEMISTRY (2019)
Prodrugs for targeted cancer therapy
Carla Souza et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2019)
Recent Advances on Reactive Oxygen Species-Responsive Delivery and Diagnosis System
Huan Ye et al.
BIOMACROMOLECULES (2019)
A Hydrogen Peroxide Activatable Gemcitabine Prodrug for the Selective Treatment of Pancreatic Ductal Adenocarcinoma
Katsunori Matsushita et al.
CHEMMEDCHEM (2019)
Reactive oxygen species-responsive drug delivery systems for the treatment of neurodegenerative diseases
William C. Ballance et al.
BIOMATERIALS (2019)
Arylboronate prodrugs of doxorubicin as promising chemotherapy for pancreatic cancer
Charles Skarbek et al.
BIOORGANIC CHEMISTRY (2019)
Oxidation-Responsive Materials: Biological Rationale, State of the Art, Multiple Responsiveness, and Open Issues
Farah El-Mohtadi et al.
MACROMOLECULAR RAPID COMMUNICATIONS (2019)
Enhanced Tumor Selectivity of 5-Fluorouracil Using a Reactive Oxygen Species-Activated Prodrug Approach
Yong Ai et al.
ACS MEDICINAL CHEMISTRY LETTERS (2019)
Boronic acids as building blocks for the construction of therapeutically useful bioconjugates
Joao P. M. Antonio et al.
CHEMICAL SOCIETY REVIEWS (2019)
Prodrug strategies for targeted therapy triggered by reactive oxygen species
Jorge Peiro Cadahia et al.
MEDCHEMCOMM (2019)
A dithiocarbamate-based H2O2-responsive prodrug for combinational chemotherapy and oxidative stress amplification therapy
Qingqing Pan et al.
CHEMICAL COMMUNICATIONS (2019)
Organic CO Prodrugs Activated by Endogenous ROS
Zhixiang Pan et al.
ORGANIC LETTERS (2018)
A cancer specific oxaliplatin-releasing Pt(IV)-prodrug
Viktor Reshetnikov et al.
DALTON TRANSACTIONS (2018)
Bioresponsive albumin-conjugated paclitaxel prodrugs for cancer therapy
Jincheng Yang et al.
DRUG DELIVERY (2018)
Therapeutic journery of nitrogen mustard as alkylating anticancer agents: Historic to future perspectives
Rajesh K. Singh et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Methotrexate prodrugs sensitive to reactive oxygen species for the improved treatment of rheumatoid arthritis
Nikolaj S. Andersen et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Tuning the structure of aminoferrocene-based anticancer prodrugs to prevent their aggregation in aqueous solution
Steffen Daum et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2018)
Thiazoles and Thiazolidinones as COX/LOX Inhibitors
Konstantinos Liaras et al.
MOLECULES (2018)
The expanding role of prodrugs in contemporary drug design and development
Jarkko Rautio et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Selective estrogen receptor modulators (SERMs) and selective estrogen receptor degraders (SERDs) in cancer treatment
Hitisha K. Patel et al.
PHARMACOLOGY & THERAPEUTICS (2018)
Biocompatible Boron-Containing Prodrugs of Belinostat for the Potential Treatment of Solid Tumors
Shilong Zheng et al.
ACS MEDICINAL CHEMISTRY LETTERS (2018)
H2O2/Peroxynitrite-Activated Hydroxamic Acid HDAC Inhibitor Prodrugs Show Antileukemic Activities against AML Cells
Yi Liao et al.
ACS MEDICINAL CHEMISTRY LETTERS (2018)
ROS-Responsive N-Alkylaminoferrocenes for Cancer-Cell-Specific Targeting of Mitochondria
Viktor Reshetnikov et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2018)
An Endogenous Reactive Oxygen Species (ROS)-Activated Histone Deacetylase Inhibitor Prodrug for Cancer Chemotherapy
Somnath D. Bhagat et al.
CHEMMEDCHEM (2018)
Discovery and Optimization of Novel Hydrogen Peroxide Activated Aromatic Nitrogen Mustard Derivatives as Highly Potent Anticancer Agents
Wenbing Chen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Rational Design of a Boron-Modified Triphenylethylene (GLL398) as an Oral Selective Estrogen Receptor Downregulator
Jiawang Liu et al.
ACS MEDICINAL CHEMISTRY LETTERS (2017)
Hydrogen peroxide activated quinone methide precursors with enhanced DNA cross-linking capability and cytotoxicity towards cancer cells
Yibin Wang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Prodrug strategy for cancer cell-specific targeting: A recent overview
Xian Zhang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Metabolism, pharmacokinetics, and bioavailability of ZB716, a Steroidal Selective Estrogen Receptor Downregulator (SERD)
Changde Zhang et al.
ONCOTARGET (2017)
Lysosome-Targeting Amplifiers of Reactive Oxygen Species as Anticancer Prodrugs
Steffen Daum et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2017)
Cancer-Specific, Intracellular, Reductive Activation of Anticancer PtIV Prodrugs
Viktor Reshetnikov et al.
CHEMISTRY-A EUROPEAN JOURNAL (2017)
A Red Light Activatable Multifunctional Prodrug for Image-Guided Photodynamic Therapy and Cascaded Chemotherapy
Li-Han Liu et al.
ADVANCED FUNCTIONAL MATERIALS (2016)
10-Boronic acid substituted camptothecin as prodrug of SN-38
Lei Wang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Fulvestrant-3 Boronic Acid (ZB716): An Orally Bioavailable Selective Estrogen Receptor Downregulator (SERD)
Jiawang Liu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Self-Assembled Redox Dual-Responsive Prodrug-Nanosystem Formed by Single Thioether-Bridged Paclitaxel-Fatty Acid Conjugate for Cancer Chemotherapy
Cong Luo et al.
NANO LETTERS (2016)
HDACs and HDAC Inhibitors in Cancer Development and Therapy
Yixuan Li et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2016)
HDAC Inhibitors as Epigenetic Regulators of the Immune System: Impacts on Cancer Therapy and Inflammatory Diseases
Elizabeth E. Hull et al.
BIOMED RESEARCH INTERNATIONAL (2016)
ROS-responsive drug delivery systems
Jing Liang et al.
BIOENGINEERING & TRANSLATIONAL MEDICINE (2016)
Selenium compounds as therapeutic agents in cancer
Aristi P. Fernandes et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2015)
Activity of aminoferrocene-based prodrugs against prostate cancer
Margot Schikora et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)
Boronic prodrug of 4-hydroxytamoxifen is more efficacious than tamoxifen with enhanced bioavailability independent of CYP2D6 status
Qiu Zhong et al.
BMC CANCER (2015)
Boronic prodrug of endoxifen as an effective hormone therapy for breast cancer
Changde Zhang et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
Exploring hydrogen peroxide responsive thiazolidinone-based prodrugs
Christian Perez et al.
CHEMICAL COMMUNICATIONS (2015)
Improved Synthesis of N-Benzylaminoferrocene-Based Prodrugs and Evaluation of Their Toxicity and Antileukemic Activity
Steffen Daum et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Dual-Mode HDAC Prodrug for Covalent Modification and Subsequent Inhibitor Release
Kevin B. Daniel et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Amplification of oxidative stress by a dual stimuli-responsive hybrid drug enhances cancer cell death
Joungyoun Noh et al.
NATURE COMMUNICATIONS (2015)
HDAC inhibitor-induced drug resistance involving ATP-binding cassette transporters
Xuan Ni et al.
ONCOLOGY LETTERS (2015)
Selection of boron reagents for Suzuki-Miyaura coupling
Alastair J. J. Lennox et al.
CHEMICAL SOCIETY REVIEWS (2014)
Aromatic Nitrogen Mustard-Based Prodrugs: Activity, Selectivity, and the Mechanism of DNA Cross-Linking
Wenbing Chen et al.
CHEMISTRY-A EUROPEAN JOURNAL (2014)
Reactive Oxygen Species (ROS) Inducible DNA Cross-Linking Agents and Their Effect on Cancer Cells and Normal Lymphocytes
Wenbing Chen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
The Leaving Group Strongly Affects H2O2-Induced DNA Cross-Linking by Arylboronates
Sheng Cao et al.
JOURNAL OF ORGANIC CHEMISTRY (2014)
Discovery of alkenylboronic acids as neuroprotective agents affecting multiple biological targets involved in Alzheimer's disease
Karim Jimenez-Aligaga et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Substituent Effects on Oxidation-Induced Formation of Quinone Methides from Arylboronic Ester Precursors
Sheng Cao et al.
CHEMISTRY-A EUROPEAN JOURNAL (2013)
Post SELECT: selenium on trial
Arun K. Sharma et al.
FUTURE MEDICINAL CHEMISTRY (2013)
Aminoferrocene-Based Prodrugs and Their Effects on Human Normal and Cancer Cells as Well as Bacterial Cells
Paul Marzenell et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
ROS-Inducible DNA Cross-Linking Agent as a New Anticancer Prodrug Building Block
Sheng Cao et al.
CHEMISTRY-A EUROPEAN JOURNAL (2012)
Aminoferrocene-Based Prodrugs Activated by Reactive Oxygen Species
Helen Hagen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Boron-Based 4-Hydroxytamoxifen Bioisosteres for Treatment of de Novo Tamoxifen Resistant Breast Cancer
Quan Jiang et al.
ACS MEDICINAL CHEMISTRY LETTERS (2012)
ROS-activated anticancer prodrugs: a new strategy for tumor-specific damage
Xiaohua Peng et al.
THERAPEUTIC DELIVERY (2012)
Activation of sulfonate ester based matrix metalloproteinase proinhibitors by hydrogen peroxide
Kevin B. Daniel et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2011)
Hydrogen Peroxide Inducible DNA Cross-Linking Agents: Targeted Anticancer Prodrugs
Yunyan Kuang et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2011)
Quinone Methides Tethered to Naphthalene Diimides as Selective G-Quadruplex Alkylating Agents
Marco Di Antonio et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2009)
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
Dunyaporn Trachootham et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Epigenetic interplay between histone modifications and DNA methylation in gene silencing
Thomas Vaissiere et al.
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH (2008)
Prodrugs: design and clinical applications
Jarkko Rautio et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Tumor-targeted induction of oxystress for cancer therapy
J. Fang et al.
JOURNAL OF DRUG TARGETING (2007)
A design of fluorescent probes for superoxide based on a nonredox mechanism
H Maeda et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2005)
Strong red fluorescent probes suitable for detecting hydrogen peroxide generated by mice peritoneal macrophages
KH Xu et al.
CHEMICAL COMMUNICATIONS (2005)
Fluorescent probes for hydrogen peroxide based on a non-oxidative mechanism
H Maeda et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2004)